Elbit Imaging Ltd. (EMITF)
TASE 
Summary
EMITF Chart
Elbit Imaging Ltd. (EMITF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Elbit Imaging Ltd. ever had a stock split?
Elbit Imaging Ltd. Profile
| Real Estate Management & Development Industry | Real Estate Sector | Eran Mazor CEO | TASE Exchange | IL0010811169 ISIN |
| IL Country | 3 Employees | - Last Dividend | 26 Jun 2016 Last Split | - IPO Date |
Overview
Elbit Imaging Ltd., based in Petah Tikva, Israel, operates globally, engaging in the development, production, and marketing of therapeutic medical systems for non-invasive treatments. Originally founded in 1996 as Elbit Medical Imaging Ltd., the company underwent a name change in November 2007 to better reflect its diverse offerings. Its journey from focusing primarily on medical imaging solutions to a broader therapeutic portfolio demonstrates its evolution within the healthcare and real estate industries. The company's international presence is underscored by its involvement in both the healthcare sector, with innovative medical solutions, and the real estate sector, through the sale of plots and villas in India.
Products and Services
- Treatment-oriented Medical Systems
The core of Elbit Imaging's healthcare solutions, these medical systems utilize ultrasound beams and magnetic resonance imaging (MRI) technology. Aimed at non-invasive treatments, these systems are designed to offer therapeutic interventions without the need for surgical procedures, thereby reducing patient recovery time and improving overall treatment outcomes.
- Stem Cell-Based Medical Products
Capitalizing on the regenerative potential of stem cells, Elbit Imaging offers medical products derived principally from umbilical cord blood. These products are intended for critical applications such as bone marrow transplantation in patients suffering from severe conditions like leukemia, lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. The stem cell-based products signify the company's commitment to pioneering in the field of regenerative medicine, providing new hope for patients with previously untreatable conditions.
- Real Estate in India
Expanding beyond its medical technology footprint, Elbit Imaging also ventures into the real estate market in India. The company's involvement includes the sale of plots and villas, tapping into the growing demand for quality housing and investment properties in one of the world's fastest-growing economies. This diversification exemplifies Elbit Imaging's strategy to explore new business opportunities and revenue streams outside its core focus, leveraging its expertise and reputation for delivering high-value projects.
